In some preliminary studies, treatments such as sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors were found to have the potential to treat DCM [20–22]. The gene discussed is DPP4; the disease is familial dilated cardiomyopathy.